Do peptides like GHK-Cu actually improve cognitive function?

What's this video probably claiming?

Based on the caption and hashtags, @haylihealth is likely walking viewers through a list of peptides, with GHK-Cu being the most explicitly called out, and suggesting they support cognitive function. The ADHD hashtag is a red flag. It implies these compounds might help with attention, focus, or executive function, which is a significant leap from what any peer-reviewed literature actually supports for human use. The creator points to a clinic for more information, which is a common content pattern that blurs the line between education and marketing. Peptides are a broad and genuinely interesting category of compounds, but conflating "bioactive" with "cognitively enhancing" is the kind of oversimplification that can mislead people who are already struggling with real neurological symptoms and looking for alternatives to conventional treatment.

What does the science actually show?

GHK-Cu (glycine-histidine-lysine-copper) has a legitimate research base, but most of it is either in vitro or animal-derived. Pickart and Margolina (2018, Frontiers in Aging Neuroscience) summarized evidence that GHK-Cu modulates gene expression in ways that could theoretically support neuroplasticity, but "modulates gene expression in cell cultures" is very different from "improves your focus." A 2020 review in Biomolecules noted that tripeptides including GHK showed neuroprotective signals in rodent models of oxidative stress. Human clinical trials for cognitive outcomes? Essentially nonexistent. Semax, also in the peptide category referenced by this creator's content area, has slightly more human data from Russian research, but those studies are small, poorly controlled, and not replicated in Western clinical settings. The honest summary: promising signals, no solid human evidence for cognitive enhancement in otherwise healthy individuals.

Where does the social media noise diverge from clinical reality?

The ADHD hashtag is where things get genuinely problematic. There is no published clinical trial demonstrating that GHK-Cu or most peptides in this category reduce ADHD symptoms in humans. Associating a compound with ADHD without evidence is not just loose language, it actively misleads people who might delay or abandon treatments with actual evidence behind them, including stimulant medications and behavioral therapy, which have decades of randomized controlled trial data. The "so many kinds" framing also creates a false impression of consensus and breadth of evidence. Yes, there are many peptides. No, most of them have not been tested for cognitive outcomes in humans at any dose. Clinic referrals in these videos often lead to compounded peptide prescriptions that are not FDA-approved for cognitive indications. Viewers deserve to know that before they book a consultation based on a 60-second TikTok.

What should you actually know?

GHK-Cu is real, the chemistry is interesting, and dismissing it entirely would be intellectually lazy. Pickart's decades of research suggest it plays a role in tissue repair and may influence brain-derived neurotrophic factor (BDNF) pathways. But BDNF modulation in a petri dish does not translate automatically to cognitive gains in a living person. If you are experiencing cognitive symptoms, especially anything you suspect is ADHD-related, a peptide clinic is not the appropriate first stop. A board-certified psychiatrist or neurologist who can run proper diagnostics is. Compounded peptides exist in a regulatory gray zone. The FDA has placed several on the difficult-to-compound list, and quality control across compounding pharmacies varies considerably. Treating serious neurological symptoms with unvalidated compounds, based on social media content, carries real risk. The science might catch up someday. It has not yet.